Fundz

iX Biopharma

Singapore, Singapore · Biotechnology, Health Care, Manufacturing

iX Biopharma is a pharmaceutical company listed on Catalist, focusing on innovative pain management solutions. Its patented product, Wafermine, is a non-opioid sublingual ketamine wafer for treating acute moderate to severe pain. The company is also expanding its commercial presence in the US market.

Key facts

Headquarters
Singapore, Singapore
Employees
51
Industries
Biotechnology, Health Care, Manufacturing
Status
Private
Website
ixbiopharma.com
LinkedIn
Company page

iX Biopharma in the news

Companies similar to iX Biopharma

About iX Biopharma: questions and answers

What does iX Biopharma do?

iX Biopharma is a pharmaceutical company listed on Catalist, focusing on innovative pain management solutions. Its patented product, Wafermine, is a non-opioid sublingual ketamine wafer for treating acute moderate to severe pain. The company is also expanding its commercial presence in the US market.

Where is iX Biopharma headquartered?

iX Biopharma is headquartered in Singapore, Singapore.

How many employees does iX Biopharma have?

iX Biopharma has about 51 employees.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches iX Biopharma across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.